# Retrospective Study of IBS-D Patients Previously Receiving SBI

> **NCT02661425** · — · COMPLETED · sponsor: **Entera Health, Inc** · enrollment: 165 (actual)

## Conditions studied

- Diarrhoea Predominant Irritable Bowel Syndrome

## Interventions

- **OTHER:** EnteraGam

## Key facts

- **NCT ID:** NCT02661425
- **Lead sponsor:** Entera Health, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2016-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02661425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02661425, "Retrospective Study of IBS-D Patients Previously Receiving SBI". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02661425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*